The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. RBC Life Sciences's Revenue for the
three
months ended in Jun. 2017 was $5.74 Mil. RBC Life Sciences's average Accounts Receivable for the
three
months ended in Jun. 2017 was $1.57 Mil.
Hence, RBC Life Sciences's Receivables Turnover for the
three
months ended in Jun. 2017 was 3.66.
RBC Life Sciences (OTCPK:RBCL) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
RBC Life Sciences Receivables Turnover Related Terms
RBC Life Sciences Receivables Turnover Historical Data
* Premium members only.
The historical data trend for RBC Life Sciences's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RBCL vs SKVI, TISUQ, TECR: Receivables Turnover Comparison
For the Household & Personal Products subindustry, RBC Life Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RBC Life Sciences Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where RBC Life Sciences's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RBC Life Sciences (RBCL) has a Receivables Turnover of 3.66 as of Jun. 2017. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Receivables Turnover too high?
RBC Life Sciences' current Receivables Turnover is 3.66. The Consumer Packaged Goods industry median Receivables Turnover is 9.38. RBC Life Sciences' value of 3.66 is 61% below this industry median.
How does RBC Life Sciences' Receivables Turnover compare to SKVI and TISUQ?
RBC Life Sciences' Receivables Turnover of 3.66 can be compared against companies in the Consumer Packaged Goods industry. The industry median Receivables Turnover is 9.38. RBC Life Sciences' value of 3.66 is 61% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.38, based on 1,937 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RBC Life Sciences's current Receivables Turnover of 3.66 is 61% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on RBC Life Sciences and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RBC Life Sciences's current Receivables Turnover is 3.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Receivables Turnover of 3.66. The current Receivables Turnover is 3.66 and 61% below the Consumer Packaged Goods industry median of 9.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Receivables Turnover is 3.66 as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBCL has been successfully added to your 